LRRK2 and Parkinson disease: This data shows that PD mutations affect lysosomal activity in a cell and mutation type specific manner, with PRKN lof mutations reducing GCase activity only in ventral midbrain neurons, whereas the LRRK2 R1441G mutation reduced GCase activity only in cortical neurons.